[go: up one dir, main page]

NO20030897D0 - Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer - Google Patents

Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer

Info

Publication number
NO20030897D0
NO20030897D0 NO20030897A NO20030897A NO20030897D0 NO 20030897 D0 NO20030897 D0 NO 20030897D0 NO 20030897 A NO20030897 A NO 20030897A NO 20030897 A NO20030897 A NO 20030897A NO 20030897 D0 NO20030897 D0 NO 20030897D0
Authority
NO
Norway
Prior art keywords
active ingredient
pharmaceutically active
concentration
preparation
dosage
Prior art date
Application number
NO20030897A
Other languages
English (en)
Other versions
NO333369B1 (no
NO20030897L (no
Inventor
Stephen Charles Tindal
Christopher Clive Webster
Josephine Christine Ferdinando
Jacqueline Carol Lewis
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24606884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20030897(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of NO20030897D0 publication Critical patent/NO20030897D0/no
Publication of NO20030897L publication Critical patent/NO20030897L/no
Publication of NO333369B1 publication Critical patent/NO333369B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030897A 2000-08-29 2003-02-26 Fremgangsmate for a oke konsentrasjonen av en farmasoytisk aktiv bestanddel i forhold til fyllpreparat-viskositet for doseenheter og myk gelatinkapsel NO333369B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/649,947 US6387400B1 (en) 2000-08-29 2000-08-29 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
PCT/US2001/026711 WO2002017855A2 (en) 2000-08-29 2001-08-28 Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Publications (3)

Publication Number Publication Date
NO20030897D0 true NO20030897D0 (no) 2003-02-26
NO20030897L NO20030897L (no) 2003-02-26
NO333369B1 NO333369B1 (no) 2013-05-13

Family

ID=24606884

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030897A NO333369B1 (no) 2000-08-29 2003-02-26 Fremgangsmate for a oke konsentrasjonen av en farmasoytisk aktiv bestanddel i forhold til fyllpreparat-viskositet for doseenheter og myk gelatinkapsel

Country Status (23)

Country Link
US (1) US6387400B1 (no)
EP (1) EP1365749B1 (no)
JP (1) JP4990474B2 (no)
KR (1) KR100634571B1 (no)
CN (1) CN1237959C (no)
AT (1) ATE353009T1 (no)
AU (2) AU2002224317B2 (no)
BR (1) BRPI0113539B8 (no)
CA (1) CA2419993C (no)
CY (1) CY1106542T1 (no)
CZ (1) CZ299449B6 (no)
DE (2) DE01984557T1 (no)
DK (1) DK1365749T3 (no)
ES (1) ES2206081T3 (no)
HU (1) HU229381B1 (no)
MX (1) MXPA03001762A (no)
NO (1) NO333369B1 (no)
PL (1) PL200398B1 (no)
PT (1) PT1365749E (no)
SI (1) SI1365749T1 (no)
TW (1) TW589199B (no)
WO (1) WO2002017855A2 (no)
ZA (1) ZA200301007B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4226846B2 (ja) * 2002-06-07 2009-02-18 キャタレント・ジャパン株式会社 口腔内で崩壊可能なソフトカプセル剤
EP1684732A2 (en) * 2003-11-12 2006-08-02 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules
US9241902B2 (en) * 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
WO2005063219A2 (en) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules
CN1909891A (zh) * 2004-01-09 2007-02-07 惠氏公司 药用组合物的微乳液
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
WO2005123133A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited A process for preparing ibuprofen soft gelatin capsules
WO2006007095A2 (en) 2004-06-30 2006-01-19 Albemarle Corporation High ibuprofen content granules and their preparation and use
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
US20070053868A1 (en) 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
CN100404031C (zh) * 2006-03-13 2008-07-23 浙江万联药业有限公司 含葡萄糖酸锌、布洛芬和马来酸氯苯那敏的软胶囊组合物
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) * 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CA2690488C (en) 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CN104083339A (zh) * 2014-08-04 2014-10-08 人福普克药业（武汉）有限公司 萘普生钠软胶囊及其制备方法
CN107951857B (zh) * 2017-11-29 2019-12-24 浙江安宝药业有限公司 布洛芬软胶囊
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
WO2019224832A1 (en) * 2018-05-25 2019-11-28 Strides Shasun Limited Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
CN108904465B (zh) * 2018-10-17 2021-02-26 石药集团恩必普药业有限公司 一种布洛芬药物制剂组合物及其制备方法
CN109820833B (zh) * 2019-04-01 2022-02-01 人福普克药业（武汉）有限公司 一种快速溶出的布洛芬软胶囊及其制备方法
CN113950324A (zh) * 2019-04-26 2022-01-18 R.P.谢勒技术有限公司 微型软胶囊萘普生组合物
BR112022005755A2 (pt) * 2019-10-09 2022-06-21 Scherer Technologies Llc R P Formulações de cápsula de gel macio não animal, métodos de preparação, e métodos de uso das mesmas
US20220233452A1 (en) * 2021-01-25 2022-07-28 R.P. Scherer Technologies, Llc Mini softgel naproxen composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
JPS61501566A (ja) 1984-03-14 1986-07-31 コルビエ−ル　ジエロ−ム 有効成分の可溶化法およびそれにより得られる薬理組成物
DE3437599C2 (de) 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP3121080B2 (ja) 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
CA2281946C (en) * 1997-03-03 2007-08-07 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances

Also Published As

Publication number Publication date
AU2431702A (en) 2002-03-13
AU2002224317B2 (en) 2004-09-02
CZ299449B6 (cs) 2008-07-30
US6387400B1 (en) 2002-05-14
BR0113539A (pt) 2003-07-15
CA2419993C (en) 2008-12-23
KR20030041982A (ko) 2003-05-27
ZA200301007B (en) 2004-02-13
HUP0401224A3 (en) 2008-04-28
CN1477953A (zh) 2004-02-25
DK1365749T3 (da) 2007-06-04
NO333369B1 (no) 2013-05-13
WO2002017855A3 (en) 2003-09-25
CN1237959C (zh) 2006-01-25
ES2206081T3 (es) 2007-10-01
SI1365749T1 (sl) 2007-06-30
HUP0401224A2 (hu) 2004-11-29
BRPI0113539B8 (pt) 2021-05-25
CY1106542T1 (el) 2012-01-25
WO2002017855A2 (en) 2002-03-07
HU229381B1 (en) 2013-11-28
EP1365749A4 (en) 2005-09-07
DE60126433D1 (de) 2007-03-22
TW589199B (en) 2004-06-01
EP1365749B1 (en) 2007-01-31
HK1056326A1 (en) 2004-02-13
NO20030897L (no) 2003-02-26
BRPI0113539B1 (pt) 2017-05-09
ES2206081T1 (es) 2004-05-16
DE01984557T1 (de) 2004-04-22
JP2004526664A (ja) 2004-09-02
PL200398B1 (pl) 2009-01-30
ATE353009T1 (de) 2007-02-15
JP4990474B2 (ja) 2012-08-01
KR100634571B1 (ko) 2006-10-16
EP1365749A2 (en) 2003-12-03
PL365752A1 (en) 2005-01-10
CA2419993A1 (en) 2002-03-07
MXPA03001762A (es) 2003-06-04
DE60126433T2 (de) 2007-11-15
PT1365749E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
MY118371A (en) Tetrahydrolipstatin containing compositions
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
CA2238271A1 (en) Pharmaceutical compositions comprising flurbiprofen
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
JP2005515966A5 (no)
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
AP2003002763A0 (en) Controlled release formulations for oral administration
TR200101928T2 (tr) Geliştirilmiş kararlılığa sahip bileşimler
MXPA04004907A (es) Composiciones de acetaminofen.
BR0014440A (pt) Formulações de liberação controlada oral
GEP20043377B (en) Pharmaceutical Complex
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
DE69800210D1 (de) Wasserfreies Mittel auf Lactulosebasis
AU2019203288A1 (en) Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
MY145885A (en) Controlled release formulations for oral administration
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung

Legal Events

Date Code Title Description
MK1K Patent expired